KRAS and lung adenocarcinoma: Our findings provided compelling evidence that CREPT depletion substantially attenuated proliferation and tumorigenesis in LUAD cells harboring KRAS or EGFR mutations, and impaired KRASG12D-induced lung adenocarcinoma formation in vivo.